Resultados de la búsqueda 51-60 of 15014 for Pancreatic+cancer

  1. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  2. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  3. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Early pancreatic cancer detection. Jacksonville, Fla. The primary purpose of this study is to standardize the collection of demographic, clinical, and ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... pancreatic cancer, as well as people at high-risk.The study also aims to provide a platform for development of an interventional protocol for early ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Early pancreatic cancer detection. Jacksonville, Fla. The primary purpose of this study is to standardize the collection of demographic, clinical, and ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    ... pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    ... pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative [HER2, estrogen and progesterone receptor (ER ...